Isavuconazole in treatment of invasive fungal disease in children with malignancy or undergoing cellular therapy
Leuk Lymphoma
.
2024 Oct 16:1-4.
doi: 10.1080/10428194.2024.2416021.
Online ahead of print.
Authors
Jan Styczynski
1
,
Krzysztof Czyzewski
1
,
Ewa Demidowicz
1
,
Magdalena Wozniak
2
,
Marcin Plonowski
3
,
Malgorzata Sawicka-Zukowska
3
,
Ewa Bien
4
,
Ninela Irga-Jaworska
4
,
Tomasz Ociepa
5
,
Aleksandra Krolak
5
,
Tomasz Urasinski
5
,
Lukasz Hutnik
6
,
Anna Szmydki-Baran
6
,
Aleksandra Minkowska
6
,
Katarzyna Pikora
6
,
Paweł Laguna
6
,
Malgorzata Salamonowicz-Bodzioch
7
,
Jowita Fraczkiewicz
7
,
Krzysztof Kalwak
7
,
Katarzyna Derwich
8
,
Olga Zajac-Spychala
8
Affiliations
1
Department of Pediatric Hematology and Oncology, Collegium Medicum, Nicolaus Copernicus University Torun, Bydgoszcz, Poland.
2
Faculty of Pharmacy, Collegium Medicum, Nicolaus Copernicus University Torun, Bydgoszcz, Poland.
3
Department of Pediatric Oncology, Medical University, Białystok, Poland.
4
Department of Pediatric Hematology and Oncology, Medical University, Gdańsk, Poland.
5
Department of Pediatric Hemato-oncology and Gastroenterology, Medical University, Szczecin, Poland.
6
Department of Pediatric Hematology and Oncology and Transplantology, Medical University, Warsaw, Poland.
7
Department of Bone Marrow Transplantation, Pediatric Oncology and Hematology, Medical University, Wrocław, Poland.
8
Department of Pediatric Oncology, Hematology and Transplantology, Medical University, Poznań, Poland.
PMID:
39412390
DOI:
10.1080/10428194.2024.2416021
No abstract available